Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, biological evaluation, QSAR analysis and molecular modelling of new thiazol-benzimidazoles as EGFR inhibitors
Aladdin M. Srour, Nesreen S. Ahmed, Somaia S. Abd El‐Karim, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 18, pp. 115657-115657
Closed Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Imidazoles as Potential Anticancer Agents: An Update on Recent Studies
Pankaj Sharma, Chris LaRosa, Janet Antwi, et al.
Molecules (2021) Vol. 26, Iss. 14, pp. 4213-4213
Open Access | Times Cited: 122
A Comprehensive Account on Recent Progress in Pharmacological Activities of Benzimidazole Derivatives
Shejuti Rahman Brishty, Md. Jamal Hossain, Mayeen Uddin Khandaker, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 106
Benzimidazole based derivatives as anticancer agents: Structure activity relationship analysis for various targets
Garvit Satija, Barkha Sharma, Anish Madan, et al.
Journal of Heterocyclic Chemistry (2021) Vol. 59, Iss. 1, pp. 22-66
Closed Access | Times Cited: 77
New Benzimidazole-, 1,2,4-Triazole-, and 1,3,5-Triazine-Based Derivatives as Potential EGFRWT and EGFRT790M Inhibitors: Microwave-Assisted Synthesis, Anticancer Evaluation, and Molecular Docking Study
Heba E. Hashem, Abd El‐Galil E. Amr, Eman S. Nossier, et al.
ACS Omega (2022) Vol. 7, Iss. 8, pp. 7155-7171
Open Access | Times Cited: 51
Novel sulfonyl thiazolyl-hydrazone derivatives as EGFR inhibitors: Design, synthesis, biological evaluation and molecular docking studies
Thoraya A. Farghaly, Eman M. H. Abbas, Amerah Alsoliemy, et al.
Bioorganic Chemistry (2022) Vol. 121, pp. 105684-105684
Closed Access | Times Cited: 43
A comprehensive review on thiazole based conjugates as anti-cancer agents
Rupali Rana, Nitish Kumar, Harmandeep Kaur Gulati, et al.
Journal of Molecular Structure (2023) Vol. 1292, pp. 136194-136194
Closed Access | Times Cited: 21
Synthesis, and characterization of Ni(II), and Cu(II) metal complexes containing new azo dye ligand (N,N,N) and evaluation of their biological activities supported by DFT studies, molecular docking, ADMET profiling, drug-likeness analysis and toxicity prediction
Azal Shakir Waheeb, Masar Ali Awad, Hussein Ali Kadhim Kyhoiesh, et al.
Journal of Molecular Structure (2024) Vol. 1321, pp. 139867-139867
Closed Access | Times Cited: 10
Synthesis and biological evaluation of new derivatives of thieno-thiazole and dihydrothiazolo-thiazole scaffolds integrated with a pyrazoline nucleus as anticancer and multi-targeting kinase inhibitors
Ismail M. M. Othman, Zahra M. Al-Amshany, Nada Y. Tashkandi, et al.
RSC Advances (2021) Vol. 12, Iss. 1, pp. 561-577
Open Access | Times Cited: 49
Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure–activity relationship, and mechanisms of action (2019–2021)
Lian‐Shun Feng, Wen‐Qi Su, Jin‐Bo Cheng, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 6
Closed Access | Times Cited: 34
Synthesis of Novel 2-((3-(Benzofuran-2-yl)-1-phenyl-1H-pyrazol-4-yl)methylene)hydrazinyl-4-phenylthiazole: Potent EGFR Targeting Anticancer Agents
Sateesh Amudala, Rambabu Palabindela, Srinu Bhoomandla, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 1, pp. 34-44
Closed Access | Times Cited: 6
Novel benzothiazole hybrids targeting EGFR: Design, synthesis, biological evaluation and molecular docking studies
Eman A. Abd El‐Meguid, Gaber O. Moustafa, Hanem M. Awad, et al.
Journal of Molecular Structure (2021) Vol. 1240, pp. 130595-130595
Closed Access | Times Cited: 39
Epidermal growth factor receptor inhibitors as potential anticancer agents: An update of recent progress
Bharti Sharma, Vikram Jeet Singh, Pooja A. Chawla
Bioorganic Chemistry (2021) Vol. 116, pp. 105393-105393
Closed Access | Times Cited: 38
Benzimidazole‐based protein kinase inhibitors: Current perspectives in targeted cancer therapy
Alaa M. Ali, Samar S. Tawfik, Amany S. Mostafa, et al.
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 5, pp. 656-673
Closed Access | Times Cited: 23
Recent Advances in the Anticancer Applications of Benzimidazole Derivatives
Mohammad Mavvaji, Senem Akkoç
ChemistrySelect (2023) Vol. 8, Iss. 35
Closed Access | Times Cited: 12
Thiazole and Related Heterocyclic Systems as Anticancer Agents: A Review on Synthetic Strategies, Mechanisms of Action and SAR Studies
Sahil Sahil, Kamalpreet Kaur, Vikas Jaitak
Current Medicinal Chemistry (2022) Vol. 29, Iss. 29, pp. 4958-5009
Closed Access | Times Cited: 21
A Medicinal Chemist’s Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents
Bhupender Nehra, Bijo Mathew, Pooja A. Chawla
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 6, pp. 493-528
Closed Access | Times Cited: 19
New thiophene, thienopyridine and thiazoline-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents and multitargeting kinase inhibitors
Zahra M. Al-Amshany, Nada Y. Tashkandi, Ismail M. M. Othman, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105964-105964
Closed Access | Times Cited: 19
Design, synthesis and molecular docking simulation of oxindole-based derivatives with dual VEGFR-2 and cholinesterase inhibitory activities
Aladdin M. Srour, Dina H. Dawood, Eman S. Nossier, et al.
Journal of Molecular Structure (2022) Vol. 1271, pp. 134130-134130
Closed Access | Times Cited: 18
Design and Synthesis of Aspirin-chalcone Mimic Conjugates as Potential Anticancer Agents
Reham A. Mohamed‐Ezzat, Aladdin M. Srour
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 7, pp. 544-557
Closed Access | Times Cited: 3
Synthesis, biological evaluation, and computational studies of thiazolyl hydrazone derivatives as triple mutant allosteric EGFR inhibitors
Sonali Shinde, Aniket P. Sarkate, Sanket Rathod, et al.
Journal of the Chinese Chemical Society (2024) Vol. 71, Iss. 7, pp. 706-720
Closed Access | Times Cited: 3
Synthesis, Characterization, In Vitro Anticancer Potentiality, and Antimicrobial Activities of Novel Peptide–Glycyrrhetinic-Acid-Based Derivatives
Gaber O. Moustafa, Ahmed Shalaby, Ahmed M. Naglah, et al.
Molecules (2021) Vol. 26, Iss. 15, pp. 4573-4573
Open Access | Times Cited: 26
New quinoxaline compounds as DPP-4 inhibitors and hypoglycemics: design, synthesis, computational and bio-distribution studies
Yasmin M. Syam, Manal M. Anwar, Somaia S. Abd El‐Karim, et al.
RSC Advances (2021) Vol. 11, Iss. 58, pp. 36989-37010
Open Access | Times Cited: 24
Design, synthesis and assessment of new series of quinazolinone derivatives as EGFR inhibitors along with their cytotoxic evaluation against MCF7 and A549 cancer cell lines
Marian W. Aziz, Aliaa M. Kamal, Khaled O. Mohamed, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 41, pp. 127987-127987
Closed Access | Times Cited: 22
Benzimidazole: A Multifacted Nucelus for Anticancer Agents
Yogita Bansal, Richa Minhas, Ankit Singhal, et al.
Current Organic Chemistry (2021) Vol. 25, Iss. 6, pp. 669-694
Closed Access | Times Cited: 20
Synthesis, crystal structure, DFT calculation, Hirshfeld suface analysis and antitumor activity of 4-(tert-butyl)-5-(1H-1,2,4-triazole-1-yl)thiazole derivatives containing benzoxazinone
Lijuan Zhang, Longjian Qiu, Xuan‐Qing Xie, et al.
Journal of Molecular Structure (2024) Vol. 1310, pp. 138047-138047
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top